Completes Sale of 51% Stake in Ishwari Healthcare; Unit Ceases to Be a Subsidiary

The company has completed the sale of its entire 51.00% stake in Ishwari Healthcare Private Limited.

Mon 28 Sep 2026

Stake Divested

51.00%

Shares Sold

2,09,100 equity shares of Rs.10/- each

Sale Consideration

Rs.1.40 Crores

Buyer

Mr. Amit Jatin Mehta

Holding After Sale

Nil

What happened

Sudarshan Pharma Industries has informed BSE that it has completed the sale of shares it held in Ishwari Healthcare Private Limited, an unlisted subsidiary.

Deal details

• Shares sold: 2,09,100 equity shares of Rs.10/- each
• Stake sold: 51.00% of the total paid-up capital of Ishwari
• Buyer: Mr. Amit Jatin Mehta
• Consideration: Rs.1.40 Crores

Effect

The company's shareholding in Ishwari has been reduced from 51.00% to Nil. As a result, Ishwari has ceased to be a subsidiary of Sudarshan Pharma.

Background

This is in continuation of the company's earlier letter dated 13th August 2026 regarding the stake sale, so the previously announced transaction now stands completed.

How investors may read it

A divestment of this kind removes the subsidiary from the group structure, so Ishwari's operations and financials will no longer be consolidated with the company going forward. The disclosure was made under Regulation 30 of the SEBI Listing Regulations.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.